The World Health Organization (WHO) will launch a pilot project for biosimilars to make costly cancer treatments more widely available in low and middle income countries. As announced in a press release yesterday, WHO said that it will invite manufacturers to submit applications for “prequalification” of biosimilar versions of rituximab, a treatment for chronic lymphocytic leukemia, and breast cancer treatment trastuzumab in September this year.
Read the source article at Life Sciences IP Review
The post WHO to make biosimilars more available in poor countries appeared first on ePatientFinder®.